ZYUS LIFE SCIENCES CORPORATIONZYUS LIFE SCIENCES CORPORATIONZYUS LIFE SCIENCES CORPORATION

ZYUS LIFE SCIENCES CORPORATION

No trades
Buy ZYUS
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪44.35 M‬CAD
−0.52CAD
‪−42.59 M‬CAD
‪351.00 K‬CAD
‪22.97 M‬
Beta (1Y)
0.60

About ZYUS LIFE SCIENCES CORPORATION


CEO
Brent Harold Zettl
Headquarters
Saskatoon
Website
Founded
2018
FIGI
BBG000BC9741
ZYUS Life Sciences Corp. is a Canadian-based life sciences company. It focuses on the global development and commercialization of cannabinoid based pharmaceutical drug product candidates and exempt market therapeutics. The firm offers cGMP/EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The company was founded by Zettl Harold Brent in April 2018 and is headquartered in Saskatoon, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ZYUS is 0.74 CAD — it has decreased by −6.02% in the past 24 hours. Watch ZYUS LIFE SCIENCES CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange ZYUS LIFE SCIENCES CORPORATION stocks are traded under the ticker ZYUS.
ZYUS stock has fallen by −2.50% compared to the previous week, the month change is a −3.70% fall, over the last year ZYUS LIFE SCIENCES CORPORATION has showed a −14.94% decrease.
We've gathered analysts' opinions on ZYUS LIFE SCIENCES CORPORATION future price: according to them, ZYUS price has a max estimate of 4.00 CAD and a min estimate of 1.50 CAD. Watch ZYUS chart and read a more detailed ZYUS LIFE SCIENCES CORPORATION stock forecast: see what analysts think of ZYUS LIFE SCIENCES CORPORATION and suggest that you do with its stocks.
ZYUS reached its all-time high on Feb 8, 2008 with the price of 8.35 CAD, and its all-time low was 0.55 CAD and was reached on Dec 6, 2001. View more price dynamics on ZYUS chart.
See other stocks reaching their highest and lowest prices.
ZYUS stock is 5.41% volatile and has beta coefficient of 0.60. Track ZYUS LIFE SCIENCES CORPORATION stock price on the chart and check out the list of the most volatile stocks — is ZYUS LIFE SCIENCES CORPORATION there?
Today ZYUS LIFE SCIENCES CORPORATION has the market capitalization of ‪40.23 M‬, it has decreased by −5.45% over the last week.
Yes, you can track ZYUS LIFE SCIENCES CORPORATION financials in yearly and quarterly reports right on TradingView.
ZYUS LIFE SCIENCES CORPORATION is going to release the next earnings report on Nov 28, 2024. Keep track of upcoming events with our Earnings Calendar.
ZYUS earnings for the last quarter are −0.07 CAD per share, whereas the estimation was −0.08 CAD resulting in a 12.50% surprise. The estimated earnings for the next quarter are −0.07 CAD per share. See more details about ZYUS LIFE SCIENCES CORPORATION earnings.
ZYUS LIFE SCIENCES CORPORATION revenue for the last quarter amounts to ‪118.00 K‬ CAD, despite the estimated figure of ‪105.00 K‬ CAD. In the next quarter, revenue is expected to reach ‪111.50 K‬ CAD.
ZYUS net income for the last quarter is ‪−4.81 M‬ CAD, while the quarter before that showed ‪−3.34 M‬ CAD of net income which accounts for −44.16% change. Track more ZYUS LIFE SCIENCES CORPORATION financial stats to get the full picture.
No, ZYUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZYUS LIFE SCIENCES CORPORATION EBITDA is ‪−15.77 M‬ CAD, and current EBITDA margin is ‪−4.53 K‬%. See more stats in ZYUS LIFE SCIENCES CORPORATION financial statements.
Like other stocks, ZYUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZYUS LIFE SCIENCES CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZYUS LIFE SCIENCES CORPORATION technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZYUS LIFE SCIENCES CORPORATION stock shows the strong sell signal. See more of ZYUS LIFE SCIENCES CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.